Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
26.44
-3.96 (-13.03%)
At close: Jun 26, 2026, 4:00 PM EDT
26.83
+0.39 (1.48%)
After-hours: Jun 26, 2026, 7:54 PM EDT
Capricor Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Capricor Therapeutics stock have an average target of 54.11, with a low estimate of 38 and a high estimate of 63. The average target predicts an increase of 104.65% from the current stock price of 26.44.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Capricor Therapeutics stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 7 | 7 | 8 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 9 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $60 | Buy | Reiterates | $60 | +126.93% | Jun 26, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $54 | Buy | Reiterates | $54 | +104.24% | Jun 18, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $38 | Buy | Reiterates | $38 | +43.72% | May 29, 2026 |
| Alliance Global Partners | Alliance Global Partners | Buy Reiterates $51 | Buy | Reiterates | $51 | +92.89% | May 14, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $62 | Buy | Maintains | $62 | +134.49% | May 13, 2026 |
Financial Forecast
Revenue This Year
118.08M
Revenue Next Year
116.68M
from 118.08M
Decreased by -1.19%
EPS This Year
-0.22
from -2.26
EPS Next Year
-0.64
from -0.22
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 242.2M | 226.3M | |
| Avg | 118.1M | 116.7M | |
| Low | n/a | 8.7M |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | 91.6% | 362.7% |
| Avg | -1.2% | 131.5% |
| Low | -92.6% | -15.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.70 | 0.62 | |
| Avg | -0.22 | -0.64 | |
| Low | -2.52 | -2.57 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.